IRIS
GABANO, Elisabetta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.204
NA - Nord America 3.044
AS - Asia 880
Continente sconosciuto - Info sul continente non disponibili 8
AF - Africa 5
SA - Sud America 5
Totale 7.146
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.986
IE - Irlanda 1.082
DE - Germania 581
SE - Svezia 528
UA - Ucraina 396
IT - Italia 264
HK - Hong Kong 259
CN - Cina 248
FI - Finlandia 248
SG - Singapore 221
IN - India 100
CA - Canada 57
IR - Iran 36
GB - Regno Unito 34
BE - Belgio 22
TR - Turchia 11
FR - Francia 10
RU - Federazione Russa 9
EU - Europa 8
RO - Romania 8
NL - Olanda 5
VN - Vietnam 5
AL - Albania 4
EG - Egitto 4
LT - Lituania 4
BR - Brasile 3
AT - Austria 2
HR - Croazia 2
PL - Polonia 2
UY - Uruguay 2
ES - Italia 1
HU - Ungheria 1
PA - Panama 1
PT - Portogallo 1
ZA - Sudafrica 1
Totale 7.146
Salva come PNG Salva come JPEG
Città #
Dublin 1.075
Jacksonville 746
Dearborn 412
Hong Kong 259
Chandler 217
Wilmington 186
Singapore 158
Ann Arbor 146
Lawrence 134
Princeton 134
Beijing 105
Piemonte 104
San Mateo 90
Andover 84
Ashburn 59
Bremen 50
Grafing 49
Toronto 48
Munich 43
Helsinki 25
Leawood 21
Brussels 20
Los Angeles 20
Cave Creek 19
Hefei 19
Monmouth Junction 18
Woodbridge 18
Zanjan 18
Nanjing 17
Santa Clara 16
Boardman 15
Kunming 15
Norwalk 15
Kocaeli 11
Guangzhou 10
Ardabil 9
Fairfield 9
Jinan 9
Augusta 8
Hebei 8
Houston 7
Novara 7
Udine 7
Wuhan 7
London 6
Mülheim 6
Sacramento 6
Shenyang 6
Winnipeg 6
Como 5
Fuzhou 5
Gunzenhausen 5
Ronco 5
Turin 5
Dong Ket 4
Frankfurt am Main 4
Menlo Park 4
Milan 4
Trieste 4
Villar Focchiardo 4
Asti 3
Bulandshahr 3
Cairo 3
Cambridge 3
Carpi 3
Chengdu 3
Lucca 3
Moscow 3
Ningbo 3
Padova 3
Quzhou 3
Rome 3
Zhengzhou 3
Bari 2
Biella 2
Borgomanero 2
Changchun 2
Chaoyang 2
Des Moines 2
Düsseldorf 2
Espoo 2
Giaveno 2
Hayward 2
Henderson 2
Huskvarna 2
Innsbruck 2
Lerici 2
Montevideo 2
Nanchang 2
New York 2
Rio de Janeiro 2
Seattle 2
Sherbrooke 2
Simi Valley 2
Taizhou 2
Tirana 2
Torino 2
Volpedo 2
Waanrode 2
Wenzhou 2
Totale 4.619
Salva come PNG Salva come JPEG
Nome #
Transition metal carbonyl clusters in biology: A futile or niche research area? 98
Cisplatin and valproate released from the bifunctional [Pt(IV)Cl2(NH3)2(valproato)2] antitumor prodrug or from liposome formulations: who does what? 93
Antiproliferative Activity of Pt(IV) Conjugates Containing the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Ketoprofen and Naproxen 92
Different strategies to exploit Pt(IV) complexes as pro-drugs 90
The antiproliferative activity of dicobalt-hexacarbonyl-aspirin complex on different malignant pleural mesotelioma phenotypes 88
Estradiol as Carrier For Selective Delivery of Cytotoxic Pt(II) Complexes to Cancer Cell Nuclei 83
Cellular trafficking, accumulation and DNA platination of a series of cisplatin-based dicarboxylato Pt(IV) prodrugs 82
Moving the paradigm in platinum-based chemotherapy from Pt(II) to Pt(IV) complexes? 80
Experimental (RP-HPLC) and theoretical (MIFs) study of the lipophilicity of a series of Pt(IV) complexes 79
195Pt NMR chemical shift: a chemometric approach 79
Hybrid inorganic (nonporous silica)/organic (alginate) core-shell platform for targeting a cisplatin-based Pt(IV) anticancer prodrug 76
Pt(IV) Bifunctional Prodrug Containing 2-(2-Propynyl)octanoato Axial Ligand: Induction of Immunogenic Cell Death on Colon Cancer 76
Experimental and molecular modeling approaches to determine the lipophilicity of a Pt(IV) pro-drugs 75
Beyond the Pt(II)-based chemotherapy: Pt(IV) complexes as oral anticancer pro-drugs 74
A different way for the oxidation of the Pt(II) complexes 74
Antiproliferative activity of Pt(IV)-bis(carboxylato) conjugates on malignant pleural mesothelioma cells 74
Antiproliferative Pt(IV) complexes: synthesis, biological activity, and quantitative structure-activity relationship modeling 73
Host-guest inclusion systems of Pt(IV)-bis(benzoato) anticancer drug candidates and cyclodextrins 73
Antiproliferative activity of a series of cisplatin-based Pt(IV)-acetylamido/carboxylato prodrugs 73
Pyrazolyl-diamine Pt(II) complexes bearing DNA-intercalating moieties: Synthesis, characterization and in vitro evaluation 71
Application of microwave-assisted heating to the synthesis of Pt(II) complexes 70
Antiproliferative Activity of PtII Complexes with Carboxylated Phosphanes in Chelated or Ring-Opened Forms 69
Functional fluorescent nonporous silica nanoparticles as carriers for Pt(IV) anticancer prodrugs 69
A New Entry to Asymmetric Platinum(IV) Complexes via Oxidative Chlorination 68
Bidentate and tridentate pyrazolyl-containing Pt(II) complexes: synthesis, characterization and in vitro evaluation 67
Assessment of the anticancer potentiality of a new platinum nanoparticulate coniugate 65
Two are (not always) better than one: the case of bifunctional platinum(IV) drugs 65
Biological activity of a series of cisplatin-based aliphatic bis(carboxylato) Pt(IV) prodrugs: How long the organic chain should be? 65
May glutamine addiction drive the delivery of antitumor cisplatin-based Pt(IV) prodrugs? 65
Functionalized nonporous silica nanoparticles as carriers for Pt(IV) anticancer prodrugs 65
Prediction of logP for Pt(II) and Pt(IV) complexes: Comparison of statistical and quantum-chemistry based approaches 65
Study of the synthesis, antiproliferative properties, and interaction with DNA and polynucleotides of cisplatin-like Pt(II) complexes containing carcinogenic polyaromatic amines 64
Synthesis and characterization of cyclohexane-1R,2R-diamine-based Pt(iv) dicarboxylato anticancer prodrugs: their selective activity against human colon cancer cell lines 64
The cisplatin-based Pt(IV)-diclorofibrato multi-action anticancer prodrug exhibits excellent performances also under hypoxic conditions 64
Synthesis, characterization and antiproliferative activity on mesothelioma cell lines of bis(carboxylato)platinum(IV) complexes based on picoplatin 63
An unsymmetric cisplatin-based Pt(IV) derivative containing 2-(2-propynyl)octanoate: A very efficient multi-action antitumor prodrug candidate 63
The hexacarbonyldicobalt derivative of aspirin acts as a CO-releasing NSAID on malignant mesothelioma cells 62
Evaluation of Platinum–Ethacrynic Acid Conjugates in the Treatment of Mesothelioma 61
Antitumor platinum(IV) pro-drugs: synthesis, characterization, cytotoxicity and QSAR analysis 61
Pt(IV) – histone deacetylase inhibitor conjugates for citotoxicity studies on MPM cells 61
Pt(IV) complexes as anticancer prodrugs 61
A step towards development of promising trypanocidal agents: Synthesis, characterization and in vitro biological evaluation of ferrocenyl Mannich base-type derivatives 61
Pros and cons of bifunctional platinum drugs: two are (not always) better than one 60
Bifunctional Pt-ethacrynic acid conjugates for malignant mesothelioma 58
Synthesis, characterization and antiproliferative activity of platinum(IV) derivates of picoplatin 58
Unprecedented one-pot synthesis of an unsymmetrical cisplatin-based Pt(IV)-acetamidato complex 58
Solvolysis of a Series of Cisplatin-Like Complexes – Comparison between DNA-Biosensor and Conductivity Data 58
Polyanionic Biopolymers for the Delivery of Pt(II) Cationic Antiproliferative Complexes 58
A view on multi-action Pt(IV) antitumor prodrugs 58
Effects of dimethylsulfoxide and ethanol on the cytotoxic activity of titanocene dichloride 57
Cytotoxicity of some Pt(II)-diamine complexes: a QSAR evaluation of the effect of chelating arms and leaving groups 57
Pt-195 NMR spectroscopy: A chemometric approach 57
Cytotoxicity of cis-platinum(II) conjugate models. The effect of chelating arms and leaving groups on cytotoxicity: A quantitative structure-activity relationship approach 56
Bioinorganic chemistry: the study of the fate of platinum-based antitumour drugs 55
Metallo-drugs in the Treatment of Malignant Pleural Mesothelioma 55
Anthracene-terpyridine metal complexes as new G-quadruplex DNA binders 55
Cis,cis,trans-[PtIVCl2(NH3)2(perillato)2], a dual-action prodrug with excellent cytotoxic and antimetastatic activity 55
Experimental determination and modeling of the lipophilicity in platinum complexes 53
Bifunctional Ethacrynic Acid – Pt Conjugates: In vitro Treatment of Malignant Pleural Mesothelioma 53
How to obtain Pt(IV) complexes suitable for conjugation to nanovectors from the oxidation of [PtCl(terpyridine)]+ 53
Solvolysis of Cisplatin and N-Methylated cis-[PtCl2(en)] Complexes – Comparison between DNA-Biosensor and Conductivity Data 52
Synthesis of PtIV-Biomolecule Conjugates through Click Chemistry 52
Assessment of the in vivo antiproliferative activity of a novel platinum nanoparticulate pharmacophore 51
Molecular Interaction Fields vs. Quantum-Mechanical-based descriptors in the modelling of lipophilicity of platinum(IV) complexes 51
Assessment of the in vivo antiproliferative activity of a novel particulate pharmacophore 50
Pt(IV)/Re(I) Chitosan Conjugates as a Flexible Platform for the Transport of Therapeutic and/or Diagnostic Anticancer Agents 50
Classical Pt(II) anticancer complexes revised in view of drug targeting and delivery 49
Biological Activity of Enantiomeric Complexes [PtCl2L2] (L2 = Aromatic Bisphosphanes and Aromatic Diamines) 49
Cellular uptake of antitumor platinum(II)-complexes evaluated by means of ICP-MS technique 48
Functionalized thymidine derivatives as carriers for the γ-emitter technetium tricarbonyl moiety 48
The influence of temperature on antiproliferative effects, cellular uptake and DNA platination of the clinically employed Pt(II)-drugs 47
In Vitro And In Vivo Activity Of A New Platinum Nanoparticulate Coniugate 46
Molecular and statistical modeling of reduction peak potential and lipophilicity of platinum(IV) complexes 46
Pros and cons of bifunctional platinum(iv) antitumor prodrugs: two are (not always) better than one 46
A multi-methodological inquiry of the behavior of cisplatin-based Pt(IV) derivatives in the presence of bioreductants with a focus on the isolated encounter complexes 46
Organometallic compounds in the discovery of new agents against kinetoplastid-caused diseases 45
Synthesis And Characterization of Estradiol Derived Platinum Complexes 44
Estrogenic carriers for cytotoxic Pt(II) complexes: light and shade 44
Study of methylation of carrier ligands in cis-[APtCl2] (A = substituted ethylenediamine) complexes 44
log Po/w determination for a series of Pt(II) complexes by means of reverse phase HPLC 44
Poly(methylmetacrylate) (PMMA) core-shell nanospheres act as efficient pharmacophores for the antiproliferative [PtCl3(NH3)]- complex by forming ionic couples 44
Pt(II) complexes with bidentate and tridentate pyrazolyl-containing chelators: synthesis, structural characterization and biological studies 44
Trend in cytotoxic activity of a series of cis-[APtCl(2)] (A = ethylenediamine methylated at different positions) complexes 44
trans,cis,cis-Bis(benzoato)dichlorido(cyclohexane-1R,2R-diamine)platinum(IV): a Prodrug Candidate for the Treatment of Oxaliplatin-Refractory Colorectal Cancer 44
Platinum(II) and technetium(I) complexes anchored to ethynylestradiol: a way to drug targeting and delivery 44
Conjugation between maleimide-containing Pt(IV) prodrugs and furan or furan-containing drug delivery vectors via Diels-Alder cycloaddition 44
Freshening up Old Methods for New Students: A Colorful Laboratory Experiment to Measure the Formation Constants of Ni(II) Complexes Containing Ethane-1,2-Diamine 44
Ethynylestradiol-Pt(II) complexes for selective drug targeting 43
Synthesis and characterisation of estrogenic carriers for cytotoxic Pt(II) fragments: biological activity of the resulting complexes 43
Electrochemical evaluation of the interaction between antitumoral titanocene dichloride and biomolecules 43
Stepwise Assembly of Platinum-Folic Acid Conjugates 43
The RP-HPLC measurement and QSPR analysis of log Po/w values of several Pt(II) complexes 43
HPLC method for the determination of monomer conversion and composition during the poly(styrene-r-methylmethacrylate) polymerization 43
Estradiol Derivatives as Carrier For Selective Vehiculation of Cytotoxic Pt(II) Complexes Towards Cancer Cells 42
Ethynylestradiol Derivatives as Carrier for Selective Vehiculation of Cytotoxic Pt(II)-Malonate and Radioactive Tc Fragments Towards Cancer Cells 42
Relationship Among Potency (IC50), Reduction Potential (E°’) And Partition Coefficient (log Po/w) Of New Antitumour Pt(IV) Complexes 42
Studies on Log Po/w of Quinoxaline di-N-Oxides: A Comparison of RP-HPLC Experimental and Predictive Approaches 42
Application of the anthraquinone drug rhein as an axial ligand in bifunctional Pt(iv) complexes to obtain antiproliferative agents against human glioblastoma cells 41
The drug targeting and delivery approach applied to Pt-antitumour complexes. A coordination point of view 41
The Relevance of Polar Surface Area (PSA) in Rationalizing Biological Properties of Several cis-Diamminemalonatoplatinum(II)-derivatives 41
Totale 5.844
Salva come PNG Salva come JPEG
Categoria #
all - tutte 42.298
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.298
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.068 0 0 0 0 0 249 324 72 156 123 138 6
2020/2021914 132 7 135 9 106 27 141 4 150 46 140 17
2021/2022979 64 17 110 114 42 0 138 27 64 23 174 206
2022/20232.176 148 89 159 48 133 204 45 125 1.085 35 69 36
2023/2024676 48 59 57 11 103 0 130 8 9 4 146 101
2024/2025284 16 49 88 25 70 36 0 0 0 0 0 0
Totale 7.313